Effect of ATRA and ATO on the expression of tissue factor in NB4 acute promyelocytic leukemia cells and regulatory function of the inflammatory cytokines TNF and IL-1β-Reference-Cited by-同舟云学术

Effect of ATRA and ATO on the expression of tissue factor in NB4 acute promyelocytic leukemia cells and regulatory function of the inflammatory cytokines TNF and IL-1β

Published:2017-03-25 Issue:6 Volume:96 Page:905-917
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Dunoyer-Geindre Sylvie,Rivier-Cordey Anne-Sophie,Tsopra Olga,Lecompte Thomas,Kruithof Egbert K. O.

Funder

Swiss Cancer Research

Fondation Dr Henri Dubois-Ferrière Dinu Lipatti

Ligue Genevoise Contre le Cancer

ISTH 2007 Presidential Fund

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00277-017-2970-5.pdf

Reference65 articles.

1. Yanada M, Matsushita T, Asou N, Kishimoto Y, Tsuzuki M, Maeda Y, Horikawa K, Okada M, Ohtake S, Yagasaki F, Matsumoto T, Kimura Y, Shinagawa K, Iwanaga M, Miyazaki Y, Ohno R, Naoe T (2007) Severe hemorrhagic complications during remission induction therapy for acute promyelocytic leukemia: incidence, risk factors, and influence on outcome. Eur J Haematol 78(3):213–219. doi: 10.1111/j.1600-0609.2006.00803.x

2. de la Serna J, Montesinos P, Vellenga E, Rayon C, Parody R, Leon A, Esteve J, Bergua JM, Milone G, Deben G, Rivas C, Gonzalez M, Tormo M, Diaz-Mediavilla J, Gonzalez JD, Negri S, Amutio E, Brunet S, Lowenberg B, Sanz MA (2008) Causes and prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and idarubicin. Blood 111(7):3395–3402. doi: 10.1182/blood-2007-07-100669

3. Stein E, McMahon B, Kwaan H, Altman JK, Frankfurt O, Tallman MS (2009) The coagulopathy of acute promyelocytic leukaemia revisited. Best Pract Res Clin Haematol 22(1):153–163. doi: 10.1016/j.beha.2008.12.007

4. Sanz MA, Montesinos P (2010) Open issues on bleeding and thrombosis in acute promyelocytic leukemia. Thromb Res 125(Suppl 2):S51–S54. doi: 10.1016/S0049-3848(10)70013-X

5. Breccia M, Lo Coco F (2014) Thrombo-hemorrhagic deaths in acute promyelocytic leukemia. Thromb Res 133(Suppl 2):S112–S116. doi: 10.1016/S0049-3848(14)50019-9

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanistic effects of arsenic trioxide on acute promyelocytic leukemia and other types of leukemias;Cell Biology International;2021-02-10

2. A Novel Aurora Kinase Inhibitor Attenuates Leukemic Cell Proliferation Induced by Mesenchymal Stem Cells;Molecular Therapy - Oncolytics;2020-09

3. Advances in the management of coagulopathy in acute promyelocytic leukemia;Thrombosis Research;2020-07

4. Treatment outcomes of patients with acute promyelocytic leukaemia between 2000 and 2017, a retrospective, single centre experience;Leukemia Research;2020-06

5. Glycated albumin stimulates expression of inflammatory cytokines in muscle cells;Cytokine;2020-04